3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine

Product Name: 3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine
CAS No.: 1262133-64-1
Chemical Name: 3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine
Synonyms: Capecitabine-5;Capecitabine USP IMp.G;Capecitabin iMpurity G;Capecitabine Impurity H;Capecitabine impurity G;Capecitabine 3-O-DR Imp;Capecitabine 3-O-BDR Imp;Capecitabine Impurity G(USP);Capecitabine Related Compound G;Capecitabine-related impurities F
CBNumber: CB02543316
Molecular Formula: C20H30FN3O9
Formula Weight: 475.47
MOL File: 1262133-64-1.mol

More

Less

3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine Property

Melting point:: 47-52°C
Density: 1.57±0.1 g/cm3(Predicted)
storage temp.: Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility: Chloroform (Slightly), Methanol (Slightly)
pka: 5.40±0.40(Predicted)
form: Solid
color: White to Off-White

More

Less

Safety

Safety Statements: 24/25
HS Code: 29321900

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Danger

Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H350May cause cancer

H360May damage fertility or the unborn child

H400Very toxic to aquatic life

H410Very toxic to aquatic life with long lasting effects

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P273Avoid release to the environment.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P321Specific treatment (see … on this label).

P332+P313IF SKIN irritation occurs: Get medical advice/attention.

P362Take off contaminated clothing and wash before reuse.

P391Collect spillage. Hazardous to the aquatic environment

P501Dispose of contents/container to..…

More

Less

N-Bromosuccinimide Price

TRC

Product number: D251005
Product name: 3’-O-(5’-Deoxy-β-D-ribofuranosyl)Capecitabine
Packaging: 1mg
Price: $305
Updated: 2021/12/16

More

Less

3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine Chemical Properties,Usage,Production

Chemical Properties

White to off-white solid

Uses

Capecitabine (C175650) impurity. Capecitabine 3-O-BDR Impurity (USP).

3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine Suppliers

Canada 1 China 48 India 4 United States 4 Global 57

J & K SCIENTIFIC LTD.

Tel: 010-82848833 400-666-7788
Fax: 86-10-82849933
Email: jkinfo@jkchemical.com
Country: China
ProdList: 96815
Advantage: 76

Chemsky（shanghai）International Co.,Ltd.

Tel: 021-50135380
Email: shchemsky@sina.com
Country: China
ProdList: 32321
Advantage: 50

S.Z. PhyStandard Bio-Tech. Co., Ltd.

Tel: 0755-4000505016 13380397412
Fax: 0755 28094224
Email: 3001272453@qq.com
Country: China
ProdList: 5047
Advantage: 50

S.Z. PhyStandard Bio-Tech. Co., Ltd.

Tel: 0755-83725681-603
Fax: +86 755 28094224
Country: China
ProdList: 4496
Advantage: 50

Beijing Comparison Pharmaceutical Technology Co., Ltd

Tel: 010-010-52878169 15801002657
Email: sales@bjcomparison.com
Country: China
ProdList: 4954
Advantage: 58

ChemStrong Scientific Co.,Ltd

Tel: 0755-0755-66853366 13670046396
Fax: 0755-28363542
Email: sales@chem-strong.com
Country: China
ProdList: 18042
Advantage: 56

Wuxi Zhongkun Biochemical Technology Co., Ltd.

Tel: 0510-85629785 18013409632
Fax: 051085625359
Email: sales@reading-chemicals.com
Country: China
ProdList: 15178
Advantage: 58

Nanjing XiZe Biotechnology CO., Ltd.

Tel: 025-66023220 0086-15250997978
Fax: 025-58362220
Email: 1511893459@qq.com
Country: China
ProdList: 7850
Advantage: 55

BOC Sciences

Tel: 16314854226
Email: info@bocsci.com
Country: United States
ProdList: 9923
Advantage: 65

Tonichem Pharmaceutical Technology Co., Ltd.

Tel: +86 (0752) 222-7171, +86 15815821171
Fax: +86 (0752) 222-6171
Country: China
ProdList: 1120
Advantage: 58

1262133-64-1, 3'-O-(5'-Deoxy-α-D-ribofuranosyl) CapecitabineRelated Search:

alpha-Capecitabine Doxifluridine 5'-Deoxy-5-fluorocytidine 5'-Deoxy-5-fluoro-N4-(isopentyloxycarbonyl)cytidine CAPECITABINE related substance USP Capecitabine-2',3'-cyclic Carbonate 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine 5'-deoxy-5-fluore-N-[(pentoyloxy)carbonyl]cytidine 2',3'-diacetate 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine 2'-O-(5'-Deoxy-β-D-ribofuranosyl) Capecitabine Capecitabine

CAPECITABINE related substance USP

3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine

5'-Deoxy-3'-O-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-N-[(pentyloxy)carbonyl]cytidine

Capecitabine USP IMp.G

3'-(5'-Deoxy-Beta-D-ribofuranoyl) Capecitabine

Cytidine, 5'-deoxy-3'-O-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-N-[(pentyloxy)carbonyl]-

pentyl (1-((2R,3R,4S,5R)-4-(((2S,3R,4S,5R)-3,4-dihydroxy-5-methyl tetra hydrofuran-2-yl)oxy)-3-hydroxy-5-methyltetra hydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate

Capecitabine impurity G

Capecitabine Impurity H

Capecitabine Impurity G(USP)

Capecitabine 3-O-BDR Impurity (USP)

Capecitabine-related impurities F

Capecitabine Related Compound G

pentyl N-[1-[(2R,3S,5R)-4-[(2S,3S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]oxy-3-hydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate

Capecitabine impurity 1/Capecitabine USP Impurity G/Capecitabine 3-O-BDR Impurity

Capecitabin iMpurity G

Capecitabine 3-O-BDR Imp

Capecitabine impurity 1/Capecitabine USP Impurity G/Capecitabine 3-O-BDR Impurity/3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine

Capecitabine-5

3'-O-(5'-Deoxy-beta-D-ribofuranosyl) Capecitabine

Capecitabine 3-O-DR Imp

3’-O-(5’-Deoxy-β-D-ribofuranosyl) Capecitabine

[1-[5-Deoxy-3-O-(5-deoxy-β-D-ribofuranosyl)-β-D-ribofuranosyl] -5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]-carbamic acid pentyl ester

3'-O-(5'-Deoxy-α-D-ribofuranosyl) Capecitabine

1262133-64-1

Bases & Related Reagents

Carbohydrates & Derivatives

Impurities

Intermediates & Fine Chemicals

Nucleotides

Pharmaceuticals